10x Genomics develops instruments, consumables, and software for single-cell and spatial biology, enabling researchers to analyze gene expression and tissue at the cellular level.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Stanley Druckenmiller / Duquesne | 95 | New buy | 403,100 | $15,455 | 0.3% |
| Steve Cohen / Point72 | 76 | New buy | 1,852,776 | $71,035,432 | 0.1% |
| Bridgewater | 56 | Trimmed -62% | 13,375 | $512,798 | 0.0% |
| Report | Date | Stance |
|---|---|---|
| #97 — Rough Seas Make Strong Sailors: Navigating the Healthcare Policy Tsunami | 2025-05-28 | WATCH |
| #92 — Market Memo: Talk to Me, Goose | 2025-04-13 | SHORT |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-09-24.